Suven Pharmaceuticals Limited
Suven Pharmaceuticals Limited (SUVENPHAR.NS) Stock Overview
Explore Suven Pharmaceuticals Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
412.4B
P/E Ratio
164.22
EPS (TTM)
$10.90
ROE
0.13%
SUVENPHAR.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Suven Pharmaceuticals Limited (SUVENPHAR.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1237.78.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 164.22 and a market capitalization of 412.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.